Laurus Labs informs about press release

22 Jul 2019 Evaluate

Laurus Labs has informed about the launch of the generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company. Rising recently received the final approval from the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA). A press release to this extent is also attached. 

\The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1014.90 -3.20 (-0.31%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×